Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-001625
Filing Date
2022-02-09
Accepted
2022-02-09 15:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27642
2 filename2.txt TEXT-EXTRACT 1438
  Complete submission text file 0000000000-22-001625.txt   40131
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filed for) CIK: 0001750149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)